Berkshire Hathaway Inc. (BRK.A)’s Future after Buffet

Speculation has been going on for ages, as to who would replace the Oracle of Omaha as the Chairman and CEO of Berkshire Hathaway Inc. (NYSE:BRK.A). The conglomerate that Warren Buffett has created, under Berkshire Hathaway Inc. (NYSE:BRK.A) spans industries and sectors, and most predict that someone from inside Berkshire Hathaway would be leading it in the future. Berkshire Hathaway posted an amazing second quarter results, the company now has in excess of $55 billion in cash reserves, more than it ever had in the past.

Warren Buffett portrait

Lawrence A. Cunningham, author of the soon to be released book, ‘Berkshire Beyond Buffett’ discussed the future of Berkshire Hathaway Inc. (NYSE:BRK.A) on Fox Business News.

“[...] $56 [billion] sounds as a lot of cash, but $20 [billion] of it will sit in Berkshire Hathaway Inc. (NYSE:BRK.A)’s coffers like always, to show financial strength. Capital expenditures at BNSF and BH Energy are going to be around $10 or $12 billion in the coming year. BH Energy itself is looking at some acquisitions, especially in the renewable space that might absorb another 10 or 12 [billion dollars] and several of the subsidiaries are always looking for acquisitions […],” Cunningham said.

Cunningham believes that even though Berkshire Hathaway Inc. (NYSE:BRK.A) constitutes of a large number of subsidiaries, all these companies are tied by a core set of common values. Out of the nine common values that all these subsidiaries have, the most prominent among them according to Cunningham is that they all are committed in their business for the long term just like Buffett is.

“His job is going to be split into three different segments, a CEO, a CIO and a chairman of the board and for the CEO spot, I polled hundreds of shareholders for this book and asked them to name three people they’ll be happy to see succeed him […] but, I got a dozen of names that were identified scores of time. So, there is a deep bench there,” Cunningham said.


 Disclosure: None

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!